Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients With Severe Parkinson's Disease
- 1 June 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 46 (6), 615-631
- https://doi.org/10.1001/archneur.1989.00520420033021
Abstract
• By using stereotaxic surgical techniques, ventral mesencephalic tissues from aborted human fetuses of 8 to 10 weeks' gestational age were implanted unilaterally into the striata in two patients with advanced Parkinson's disease. The patients were treated with a cyclosporine, azathioprine, and steroid regimen to minimize the risk for graft rejection. They were examined for 6 months preoperatively and 6 months postoperatively and continued to receive the same doses of antiparkinsonian medication. There were no significant postoperative complications. No major therapeutic effect from the operation was observed. However, in the clinical tests, both patients showed small but significant increases of movement speed for repeated pronation-supination, fist clenching, and foot lifting. The rate of walking also increased in the one patient tested. For both patients, there was an initial worsening postoperatively, followed by improvement vs preoperative performance at 1 to 3 months. Both patients also showed significant improvement in the magnitude of response to a single dose of levodopa (l-dopa), but there was no increase in the duration of drug action. The motor readiness potential increased in both patients postoperatively, primarily over the operated hemisphere. Neurophysiological measurements also showed a more rapid performance of simple and complex arm and hand movements on the side contralateral to transplantation in one patient at 5 months postoperatively. Positron emission tomography demonstrated no increased uptake of 6-l-(18F)-fluorodopa in the transplanted striatum at 5 and 6 months. Taken together, these results suggest that the fetal nigral implants may have provided a modest improvement in motor function, consistent with the presence of small surviving grafts. Although our results support further scientific experimentation with transplantation in Parkinson's disease, widespread clinical trials with this procedure are probably not warranted at this time.Keywords
This publication has 26 references indexed in Scilit:
- Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissuesExperimental Brain Research, 1988
- Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysisNeuroscience, 1987
- Activation of striatal dopaminergic grafts by haloperidolBrain Research Bulletin, 1985
- Substantia nigra transplants into denervated striatum of the rat: Ultrastructure of graft and host interconnectionsJournal of Comparative Neurology, 1985
- Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: An in vivo electrochemical studyBrain Research, 1985
- Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brainNeuroscience Letters, 1985
- Functional Activity of Substantia Nigra Grafts Reinnervating the Striatum: Neurotransmitter Metabolism and [14C]2‐Deoxy‐d‐glucose AutoradiographyJournal of Neurochemistry, 1982
- Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testingBrain Research, 1980
- Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplantsBrain Research, 1979
- Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine SystemScience, 1979